ABSTRACT. Botulinum C3 enzyme produced by Clostridium botulinum type C and D strains modifies Rho proteins. In a previous study, we observed that the LDH isozyme pattern of neurons treated with C3 enzyme was different from that induced with endogenous growth factor of neurons such as NGF [21] . This type of change is considered to have an advantage in the medical use of C3 enzyme for neural disorder. To determine the functional similarity of C3-treated neurons to control and NGF-treated neurons, we examined the responses of C3-treated neurons to various drugs, including some neurotransmitters, by measuring the rise of intracellular Ca ions into the neurons. The time course of the rise of intracellular Ca ions induced by high concentration of potassium in the C3-treated neurons was similar to that in the NGF-treated neurons. The C3-treated neurons responded to glutamic acid, aspartic acid, kainic acid, γ-aminobutylic acid, muscarine and ACh with similar time courses and magnitudes as the control neurons. These results suggest that the C3 enzyme induces the functional differentiation of neurons, and that C3 enzyme has the potential for the medical use as an exogenous differentiation-inducing factor of neurons.-KEY WORDS: botulinum C3 enzyme, Ca 2+ , differentiation, neuron, neurotransmitter.
Botulinum C3 enzyme was first reported as a new type of botulinum toxin with an ADP-ribosyl transferase activity [1] . C3 enzyme has the unique function of inducing a morphological change in cells when they are incubated with it. Since the morphological change of neural cells caused by C3 enzyme seems to be a differentiation of cells, the effects of C3 enzyme on induction of differentiation marker enzymes have been examined. C3 enzyme increases choline acetyl transferase, acetylcholine esterase and 2', 3'-cyclic-nucleotide 3'-phosphohydrolase in NG108-15 and C6 cell lines [12] . These facts suggest that C3 enzyme has a differentiation-inducing activity on neurons.
We obtained results in previous studies on the change of the lactate dehydrogenase (LDH) isozyme pattern; the ratio of H-subunit to M-subunit in LDH was decreased significantly by C3 enzyme treatment in primary cultured neurons. Also, the ratio of H/M in LDH was increased by nerve growth factor (NGF) and N6, 2'-O-dibutyryl 3', 5'-cyclic monophosphate (DBcAMP) [21] . These results suggest that the C3 enzyme induces an intracellular state in which less oxygen is consumed in primary cultured neurons. The change in the characteristics of the neuron to the intracellular reduced oxygen consumption state has important benefits for the treatment of ischemia. These results motivated us to study the potential of the C3 enzyme as an exogenous differentiation-inducing factor for neurons. To evaluate the potential of C3 enzyme, it is necessary to determine the response of the C3-treated neurons to various physiological and pharmacological substances.
In this study, we examined the responses of C3-treated neurons to various drugs, including some neurotransmitters, by measuring the rise of intracellular Ca 2+ as an indicator of the physiological function of the neural cell.
MATERIALS AND METHODS
Purification of C3 enzyme: C3 enzyme was purified from the culture supernatant of Clostridium botulinum type C strain Stockholm as previously described [16] with a slight modification: gel filtration using high performance liquid chromatography (HPLC) with a column of Sephadex G-100 superfine (Amersham Pharmacia Biotech., Uppsala, Sweden) was followed by passing the C3 fraction which had the highest concentration after gel filtration through the affinity column coupled with anti-C1 toxin IgG to remove C1 toxin completely.
Preparation of cells for primary cultures: Primary neurons were prepared from the cerebrum of mouse (ICR) embryos on day 15 and plated on a poly-L-lysine coated glass coverslips with a diameter of 12 mm. The neurons were cultured in Dulbecco's minimum essential medium (DMEM) supplemented with 10% of fetal calf serum (FCS), 100 unit/ml of penicillin and 10 µg/ml of streptomycin under the condition of 95% air and 5% CO 2 at 37ºC. To suppress proliferation of glial cells, cytosine arabinoside (araC) was added to the culture dish at a final concentration of 10 µM on day 2, followed by change of the culture medium to fresh DMEM after incubation for 24 hr [14] .
Fluo-3 loading: At 72 hr after C3 enzyme treatment, the cultured neurons on the coverslips were washed three times with HEPES buffer containing 132 mM NaCl, 3.5 mM KCl, 1 mM MgCl 2 , 2 mM CaCl 2 , 10 mM glucose, 10 mM HEPES and 1 µM tetrodotoxin (TTX) to block Na + currents, pH 7.4 [2] . Thereafter, the neurons were incubated with a final concentration of 5 µM fluo-3 AM ester and 1% dimethyl-sulfoxide (DMSO) at 37°C for 45 min. Then the neurons were used for the imaging experiments in a novelty designed chamber (about 1.5 ml volume).
Preparation of solution containing drug or high potassium: A high potassium buffer was prepared on the base of HEPES buffer; concentrations of KCl and NaCl were 50 mM and 85.5 mM, respectively [11, 13] . Similarly, Na + -free and high potassium buffer contained 150 mM KCl without NaCl [2, 11] . The concentration of glutamate, asparatate or kainic acid used was 30 µM. These drugs were applied to the HEPES buffered solution containing 4 µM glycine [11, 19] . In the asparatate containing solution, MgCl 2 was omitted [19] . The concentrations of γ-aminobutylic acid (GABA), muscarine and acetylcholine (ACh) were 50 µM, 10 µM and 10 µM, respectively [3, 4, 6, 17, 20] . To obtain maximal or minimal fluorescence intensity due to the rise of intracellular Ca 2+ in response to 150 mM KCl, a HEPES buffered solution containing 1 µM ionomycin alone or high potassium buffer containing 10 mM EGTA was applied to the cells.
Confocal imaging: Each stimulant was perfused into the chamber at a flow rate of 4 ml per minute. Calcium imaging was conducted with a BioRad MRC-1024 confocal laser scanning microscope (CLSM), or a LEICA DMIRB microscope configured with a Yokokawa realtime confocal laser scanning unit CSU-10. The illumination source was an Argon laser with an excitation wavelength of 488 nm. The intensity of the light was reduced to 10% of the nominal intensity with neutral density filters. All images were collected at 3 or 20 second intervals.
Data analysis: The cytosolic Ca 2+ level of the neuron was assessed by determining the fluorescence intensity (F). The fluorescent level of each cell under the resting conditions served as the baseline (F1). The changes of fluorescence intensity were calculated by the following equation, RFI= (F-F0)/(F1-F0), where, RFI is the relative fluorescence intensity, and F0 is the background fluorescence. Image analysis was performed using a NIH Image program ver.1.6.2 (http://rsb.info.nih.gov/nih-image/) [4, 11, 19] .
Morphological observation: The neurons, which were cultured on the coverslips and used for the rise of intracellular Ca 2+ experiments, were fixed with 4% paraformaldehyde, immunocytochemically stained with a mouse monoclonal anti-MAP-2 antibody (Leinco Technologies. Inc.), and were observed with IX70 microscope (Olympus, Tokyo, Japan) [7] .
RESULTS
Exposure of the cultured neurons to the high potassium buffer resulted in increases of florescence intensities (Fig.  1 ). Clear neurites with high intensity fluorescence were observed in the primary cultured neurons. To confirm the increase of fluorescence intensity caused by the rise of intracellular Ca 2+ , the neurons were treated with ionomycin, Ca 2+ ionophore, or with EGTA, Ca 2+ chelator, and the fluorescence intensities were measured again. As shown in Fig. 2B , the fluorescence intensity was increased to a maximum level with ionomycin, and was decreased to 40% of the high potassium buffer with 10 mM EGTA. Based on these observations, about 60% of increase of the fluorescence intensity was attributed to the rise of intracellular Ca 2+ . Because of the varying distances between the neurons examined and the site at which the stimulant was added, there were time deviations from the start of stimulation to the fluorescence response.
The responses of the C3-treated neurons to high potassium were compared with those of the control neurons by using the same method. In the C3-treated neurons, the time course of response was essentially the same as that of the control neurons (Figs. 1 and 2A) , while the apparent increase in fluorescence intensity induced by potassium was a little higher than in the control. Furthermore, no significant differences were observed among the C3-, NGFtreated neurons and the control neurons in the time courses for 30 min (Fig. 3) .
Since the Ca 2+ response of the C3-treated neuron was considered to be similar to that of the NGF-treated neuron and of the control neurons, the responses of the neurons to various drugs were then examined. The fluorescence intensities induced by the addition of various drugs are shown in Fig. 4 . Glutamate, asparatate and kainic acid at 30 µM each caused increases in fluorescence intensity to the same level that 50 mM KCl did. Similar phenomena were obtained with the control neurons. The time course of the fluorescence response to 50 µM GABA in the C3-treated neurons was similar to that in the control neurons (Fig. 4D) . No difference in the time course and magnitude of the response to 10 µM muscarine was observed between the C3-treated neurons and the control neurons (Fig. 4E) . About 25% of the primary cultured neurons responded to 10 µM ACh. All ACh respondent cells in the control neurons showed a similar time course of Ca 2+ response when they were stimulated with KCl (50 mM), glutamate, asparatate and kainic acid. Moreover, 80% of the ACh respondent cells in the C3-treated neurons showed about two minutes of delay in the Ca 2+ response (Fig. 4F ).
DISCUSSION
In ischemic neural disorder, a number of neurons die within two weeks. In such cases, new dendrite formation from live neurons is necessary for recovery of the neural function. However, an exogenous differentiation-inducing factor has not been developed for medical use.
Since it has been reported that C3 enzyme modifies Rho proteins, and induces differentiation-like morphological change in PC-12, NG108-15 and C-6 cells [12, 18] , we examined the potential of C3 enzyme for medical use, especially in dendrite induction. We first examined the C3 act ivity for the induction of differentia tion-like morphological changes of primary cultured neurons. The morphological change was a little different from that induced by NGF. Although the difference may be attributable to a difference in signal transduction, NGF activates MAP-kinase and does not involve the Rho protein [5, 9, 15] , the functional difference still remains obscure. Then we examined the change of a metabolic enzyme, especially LDH isozyme. The LDH isozyme pattern of C3-treated neurons was changed to a reduced oxygen consumption type [21] . This type of change is considered to have an advantage over oxygen deficiency in ischemic neural disorder. Thus, C3 activity seems to offer the possibility of medical use, but a very important problem remains: it was obscure whether or not the functional responses of the C3-treated neurons to drugs were similar to these of the control neurons.
In the present study, we examined the Ca 2+ response of C3-treated neurons to various drugs, including some neurotransmitters. The rise of intracellular Ca 2+ in the primary cultured neurons was examined by measuring the increase of fluorescence intensity. Since the signal pathway involving C3 enzyme is different from that of NGF, it is possible that the response of neurons to high potassium stimulation differed from each other. However, the results showed that the intracellular Ca 2+ increase by Ca 2+ influx in the C3-treated neurons was similar to those in the control and NGF-treated neurons. Then the responses of primary cultured neurons were examined with various drugs. The responses of the C3-treated neurons to most of the drugs were similar, suggesting that they have a similar physiological function to those of control neurons.
Delayed response to ACh stimulation was observed in the C3-treated neurons. The cause of the delayed response was not known. Perhaps the expression of ACh receptors is morphologically disturbed by C3. It has been reported that the Rho protein is related to the formation of receptor complex in muture neurons [8, 10, 22] . In our experiments, essentially similar responses to drugs were observed in the C3-treated and control neurons. This suggests that further investigations on the physiological function of the C3 enzyme will promote the development in medical use of C3 enzyme as an exogenous differentiationinducing factor of neurons. 
